Amophar OTC

Schelle ·KBO/BCE: BE 0795.483.142

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	7.1%	27.4%	better than 25% of 963 sector peers
Net result	€170	€24k	better than 30% of 963 sector peers
Equity	€11k	€172k	better than 20% of 963 sector peers
Gross operating margin	€-2k	€174k	better than 14% of 961 sector peers
Total assets	€159k	€859k	better than 16% of 963 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€159k
Current assets	29/58	€159k
Stocks & contracts in progress	3	€35k
Amounts receivable within one year	40/41	€88k
Cash & bank	54/58	€29k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€159k
Equity	10/15	€11k
Contributions / capital	10/11	€10k
Accumulated profits (losses)	14	€1k
Amounts payable	17/49	€147k
Amounts payable within one year	42/48	€22k
Trade debts payable within one year	44	€13k
Income statement
Gross operating margin	9900	€-2k
Operating result	9901	€-2k
Financial income	75	€2k
Financial charges	65	€284
Result before taxes	9903	€170
Net result for the period	9904	€170
Result to be appropriated	9905	€170

Summary

Legal nameNL	Amophar OTC
AbbreviationNL	Amophar